@gregoryai.bsky.socialTolerogenic dendritic cell (tolDC) vaccines are a promising antigen-specific therapy for multiple sclerosis (MS), yet their efficacy is limited by poor homing to secondary lymphoid organs and rapid loss of the tolerogenic phenotype in na...
#MSchat #MS #Neurology #MultipleSclerosis #NeuroSky #MedSky
@lightningduck.bsky.socialHad to collapse into bed after two hard MS days. Slept longer than expected but fell asleep feeling punched
Woke up and couldn't make dinner from the pain in my joints, fog in my thought and no gyros. Cooked microwave plate that I couldn't even eat
...
@morethanms.bsky.socialI thought getting through the MRI would be the whole story.
Nope.
The fear didn’t end when they pulled me out.
I ended up writing two connected essays about the experience. Both go up tomorrow in Notes from a Changed Life.
@kevjbyrne.bsky.socialLooking for some normal after Garage Dayz October! #NeverStopNeverQuitForThem #MultipleSclerosis #MS #nationalmssociety #CanYouTRK
@newsramp.comQuantum BioPharma (NASDAQ: QNTM) receives FDA clearance for its Lucid-MS IND application, paving the way for a Phase 2 trial targeting myelin degradation in multiple sclerosis patients. A major milestone for this micro-cap biotech. #Biotech #MultipleSclerosis
@sroman.bsky.social
@msnewstoday.bsky.socialGet the scoop: https://bit.ly/4yJn4qY
Scientists have engineered a human "mini-brain" model that mimics MS damage and repair, offering a new way to test myelin-repairing therapies.
@molneurodegen.bsky.socialBeneficial vs. pathogenic #microglia functions across aging, #MultipleSclerosis, and #AlzheimersDisease
Jonathan K. Monteiro & Véronique E. Miron @uoftpress.bsky.social
@wheelieoutthere.bsky.socialWhat It’s Like To Live With Pediatric #MultipleSclerosis: A Program for Families – 10/22/26
Learn & connect w other kids, teens & young adults who know what you’re going through. Bring family or anyone else cheering you on! Meet experts for your questions.
Signup, Resources: tinyurl.com/yx8tfkny
@msnewstoday.bsky.socialDiscover more: https://bit.ly/3TtM9Hf
Quantum is working with Thermo Fisher to prepare a Phase 2 trial of Lucid-MS in progressive MS after FDA clearance.
@abudd.bsky.social@abudd.bsky.social@abudd.bsky.social
@kadavercosplay.bsky.social3rd day of infusions done! One more and I'm free for a while. Yay! 😄
#chronicillness #ms #epilepsy #multiplesclerosis #infusiontherapy
@msnewstoday.bsky.socialGet the scoop: https://bit.ly/3TLgQrd
Columnist Desiree Lama looks forward to the change in seasons this autumn as a chance to listen to her body a little more closely.
@kevjbyrne.bsky.socialWhy I did more then I could last week/month/year #NeverStopNeverQuitForThem #MultipleSclerosis #MS #nationalmssociety #CanYouTRK
@msnewstoday.bsky.socialTake a closer look: https://bit.ly/4yrR3Tz
A personalized neuropsychological rehab program may help people with MS manage cognitive issues, according to a feasibility study.
@kevjbyrne.bsky.socialGarage Dayz Rest Stop 1: 100.29 miles, 5:52 hours. Not my fastest, but uninterrupted. My brain would not let my body pause. #NeverStopNeverQuitForThem #MultipleSclerosis #MS #nationalmssociety #CanYouTRK
@msnewstoday.bsky.socialGet the scoop: https://bit.ly/4ycaYWn
Higher physical activity was linked to lower MS risk mainly among people with low sun exposure in a Swedish study.
@abudd.bsky.social